We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Xiaojiang Cui, PhD

Associate Professor, Surgery

Research Scientist, Womens Cancer Program, Cancer Institute

Send an Email

Research Office:

Phone:

310-423-7437

Xiaojiang Cui, PhD

Associate Professor, Surgery

Research Scientist, Womens Cancer Program, Cancer Institute

The research focus of Xiaojiang Cui, PhD, is to decipher biochemical and signaling mechanisms of cancer metastasis and therapeutic resistance as well as utilize these mechanisms to identify potential targets for therapeutic interventions. He is working to develop effective anticancer therapies based on these targets.

  • Editorial Board Member: Journal of Analytical Oncology, Current
  • Presentation Award, Annual Dan L. Duncan Cancer Center Retreat, Baylor College of Medicine, 2006
  • Breast Cancer SPORE Career Development Award, National Cancer Institute, 2004
  • First Place Abstract, Annual Dan L. Duncan Cancer Center Retreat, Baylor College of Medicine, 2003
  • Postdoctoral Training Award, U.S. Department of Defense Breast Cancer Research Program, 2001
  • American Association for Cancer Research, 2000
  • Endocrine Society, 2000

Show moreShow less

  • Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Sim M, Bukoye BA, Liu B, Lee AV, Lin X, Huang P, Martens JW, Giuliano AE, Zhang N, Cheng NH, Cui X. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling. J Clin Invest. 2010;121(1):212-225.
  • Ray PS, Wang J, Qu Y, Sim MS, Shamonki J, Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DS, Walter MA, Martens JW, Richardson AL, Giuliano AE, Cui X. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res. 2010;70(10):3870-3876.
  • Wang J, Kuiatse I, Lee AV, Pan J, Giuliano A, Cui X. Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation. Mol Cancer Res. 2010;8(2):266-277.
  • Wang J, Ray PS, Sim MS, Zhou XZ, Lu KP, Lee AV, Lin X, Bagaria SP, Giuliano AE, Cui X. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling. Oncogene. 2012;31(45):4798-4802.
  • Jensen TW, Ray T, Wang J, Li X, Naritoku WY, Han B, Bellafiore F, Bagaria SP, Qu A, Cui X, et al. Diagnosis of basal-like breast cancer using a FOXC1-based assay. J Natl Cancer Inst. 2015;107(8)pii:djv148.

Show moreShow less

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Xiaojiang Cui, PhD